Your session is about to expire
← Back to Search
Prostate Cancer Genius App Education for Prostate Cancer (PCGA Trial)
N/A
Recruiting
Led By Adam Alexander, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
are between the ages of 55 and 69
self-identify as "male" and "Black or African American"
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-days
Awards & highlights
PCGA Trial Summary
This trial seeks to test a Prostate Cancer Genius App to reduce the disproportionate mortality burden of prostate cancer in African American men by improving knowledge and uptake of PSA screening.
Who is the study for?
This trial is for African American men aged 55-69 living in Oklahoma who haven't had a PSA screening for prostate cancer in the last two years and have never been diagnosed with prostate cancer.Check my eligibility
What is being tested?
The study is testing the Prostate Cancer Genius App against an existing health app to see if it improves knowledge about prostate cancer risk, encourages home-based PSA testing, and is user-friendly over a period of 30 days.See study design
What are the potential side effects?
Since this trial involves educational apps rather than medical treatments, there are no direct physical side effects. However, participants may experience stress or anxiety related to learning about their potential cancer risk.
PCGA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 55 and 69 years old.
Select...
I am a Black or African American male.
PCGA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30-days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Prostate Cancer Knowledge
Secondary outcome measures
PSA screening test completion rates
PCGA Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Prostate Cancer Genius appExperimental Treatment1 Intervention
The Prostate Cancer Genius app includes the following components: (1) educational content that is consistent with existing evidence and recommendations for prostate cancer and prostate cancer screening but has been adapted for the African American male population and for adults who read at or below the 8th-grade level; (2) real-time messages about the risks of prostate cancer and the benefits of completing a PSA test, placing a special emphasis on screening considerations for individuals with a family history of prostate cancer and/or lower urinary tract symptoms (measured via the American Urological Association Symptom Score); (3) general trivia that also incorporates quiz questions about prostate cancer and the PSA test; (4) African American-specific testimonials and educational videos; (5) optional counseling by African American prostate cancer survivors; and (6) on-demand, automated ordering of a home-based PSA test.
Group II: Prevention Taskforce appActive Control1 Intervention
The Prevention Taskforce app provides on-demand access to evidence-based recommendations for prostate cancer for men between 55 and 69 (i.e., it can be accessed as needed).
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,845 Total Patients Enrolled
1 Trials studying Prostate Cancer
30 Patients Enrolled for Prostate Cancer
Adam Alexander, PhDPrincipal InvestigatorTSET Health Promotion Research Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 55 and 69 years old.I have been diagnosed with prostate cancer.I am a Black or African American male.
Research Study Groups:
This trial has the following groups:- Group 1: Prostate Cancer Genius app
- Group 2: Prevention Taskforce app
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this clinical research available to me?
"In order to join the trial, participants must demonstrate healthy habits and fall between 55 - 69 years old. Approximately 80 individuals will be accepted for this study."
Answered by AI
Are individuals of age 18 or older qualified to participate in this experimentation?
"This trial has a strict age restriction of 55-69 years old, with 90 studies for those below the legal adult age and 1348 studies for seniors."
Answered by AI
Are there any slots available for participants in this research endeavor?
"Affirmative. According to the data uploaded on clinicaltrials.gov, this medical research is actively seeking volunteers and was initially posted in February 24th 2023 before being updated two days later. The study requires 80 participants from only one trial site."
Answered by AI
How many test subjects are currently partaking in this clinical experiment?
"Affirmative. Clinicaltrials.gov contains information corroborating the fact that recruitment for this trial is still ongoing, with 80 patients required from a single location since its initial post date of February 24th 2023 to March 2nd 2023."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger